10
5
5
A resolution expressing the sense of the Senate that over 25 years of real-world evidence and hundreds of peer-reviewed studies proving that mifepristone is safe and effective should be respected, and law and policy governing access to lifesaving, time-sensitive medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science.
5/29/2026, 4:11 PM
Summary of Bill SRES 732
This is Senate Resolution 732 of the 119th Congress, introduced on May 14, 2026. The resolution expresses the Senate's support for recognizing over 25 years of evidence and numerous studies demonstrating the safety and efficacy of mifepristone. It calls for equitable, transparent laws and policies regarding access to time-sensitive medication abortion, based on peer-reviewed scientific evidence.
Read the Full Bill
Current Status of Bill SRES 732
Bill SRES 732 is currently in the status of Bill Introduced since May 14, 2026. Bill SRES 732 was introduced during Congress 119 and was introduced to the Senate on May 14, 2026. Bill SRES 732's most recent activity was Referred to the Committee on Health, Education, Labor, and Pensions. (text: CR S2309-2310) as of May 14, 2026
Bipartisan Support of Bill SRES 732
Total Number of Sponsors
1Democrat Sponsors
1Republican Sponsors
0Unaffiliated Sponsors
0Total Number of Cosponsors
46Democrat Cosponsors
44Republican Cosponsors
0Unaffiliated Cosponsors
2Policy Area and Potential Impact of Bill SRES 732
Primary Policy Focus
HealthAlternate Title(s) of Bill SRES 732
A resolution expressing the sense of the Senate that over 25 years of real-world evidence and hundreds of peer-reviewed studies proving that mifepristone is safe and effective should be respected, and law and policy governing access to lifesaving, time-sensitive medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science.
A resolution expressing the sense of the Senate that over 25 years of real-world evidence and hundreds of peer-reviewed studies proving that mifepristone is safe and effective should be respected, and law and policy governing access to lifesaving, time-sensitive medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science.
Comments
Kole Gray
841
1 month ago
I don't agree with this bill. It's not fair to force people to accept something they don't believe in. It's important to consider all perspectives and not just push one agenda. It's not right to ignore the concerns of those who may be affected by this.
Sponsors and Cosponsors of SRES 732
Latest Bills
Truman Scholarship Clean House Act
Bill HR 7894July 10, 2026
Small Business and Consumer Credit Act of 2026
Bill HR 9383July 10, 2026
Officer Leslie Coffelt U.S. Secret Service Police Act of 2026
Bill HR 9503July 10, 2026
Housing Opportunities and Preservation Enhancement Act of 2026
Bill HR 9573July 10, 2026
Congratulating the New York Knicks on winning the 2026 National Basketball Association Finals.
Bill HRES 1422July 10, 2026
Impeaching Sparkle L. Sooknanan, a Judge of the United States District Court for the District of Columbia, for high crimes and misdemeanors.
Bill HRES 1421July 10, 2026
To establish a pilot program for use by U.S. Customs and Border Protection at land ports of entry along the Arizona border to assess the use of artificial intelligence through an anomaly detection algorithm, and for other purposes.
Bill HR 9566July 10, 2026
Securing Agriculture's Workforce Act of 2026
Bill HR 9535July 10, 2026
SABER Act of 2026
Bill HR 9451July 10, 2026
Expressing the sense of the House of Representatives that Congress must urgently take all appropriate measures to guarantee civil rights and fair political representation to all Americans.
Bill HRES 1384July 10, 2026
Expressing the sense of the House of Representatives that over 25 years of real-world evidence and hundreds of peer-reviewed studies proving that mifepristone is safe and effective should be respected, and law and policy governing access to lifesaving, time-sensitive medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science.
Bill HRES 1285May 29, 2026